APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decentralized Clinical Trial Platforms

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Decentralized Clinical Trial Platforms Industry Growth and Trends Forecast to 2032

3 March 2026123 pages

Choose your research edition.

Industry ResearchDecentralized Clinical Trial Platforms Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Decentralized Clinical Trial Platforms Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Decentralized Clinical Trial Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decentralized Clinical Trial Platforms Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Decentralized Clinical Trial Platforms Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

According to APO Research, the global Decentralized Clinical Trial Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Decentralized Clinical Trial Platforms market include Medidata, IQVIA, Veeva Systems, Castor, Delve Health, Jeeva, Signant Health, Clinical Ink and ObvioHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Decentralized Clinical Trial Platforms market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Decentralized Clinical Trial Platforms market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Decentralized Clinical Trial Platforms market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Decentralized Clinical Trial Platforms.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Decentralized Clinical Trial Platforms market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Decentralized Clinical Trial Platforms Market by Company

Medidata

IQVIA

Veeva Systems

Castor

Delve Health

Jeeva

Signant Health

Clinical Ink

ObvioHealth

THREAD

Science 37

Medable, Clario

Aparito

Viedoc Technologies

Crucial Data Solutions

Medrio

Alira Health

Fortrea

Huma

Cliniv Health Tech

Datacubed Health

Decentralized Clinical Trial Platforms Segment by Type

Cloud Based

Web Based

Decentralized Clinical Trial Platforms Segment by Application

Pharmaceutical Companies

Biotechnology Firms

Contract Research Organizations (CROs)

Healthcare Institutions

Decentralized Clinical Trial Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trial Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trial Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trial Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Decentralized Clinical Trial Platforms companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Decentralized Clinical Trial Platforms Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Decentralized Clinical Trial Platforms Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Decentralized Clinical Trial Platforms Market Share by Region (2021-2026) Table 4. Global Decentralized Clinical Trial Platforms Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Decentralized Clinical Trial Platforms Market Share by Region (2027-2032) Table 6. Global Decentralized Clinical Trial Platforms Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2026) Table 9. Global Decentralized Clinical Trial Platforms Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Decentralized Clinical Trial Platforms Market Size Share Forecasted by Type (2027-2032) Table 11. North America Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Decentralized Clinical Trial Platforms Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2026) Table 24. Global Decentralized Clinical Trial Platforms Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Decentralized Clinical Trial Platforms Market Size Share Forecasted by Application (2027-2032) Table 26. North America Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Decentralized Clinical Trial Platforms Industry Trends Table 37. Decentralized Clinical Trial Platforms Industry Drivers Table 38. Decentralized Clinical Trial Platforms Industry Opportunities and Challenges Table 39. Decentralized Clinical Trial Platforms Industry Restraints Table 40. Global Decentralized Clinical Trial Platforms Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Decentralized Clinical Trial Platforms Revenue Market Share by Company (2021-2026) Table 42. Global Decentralized Clinical Trial Platforms Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Decentralized Clinical Trial Platforms Key Company Headquarters & Area Served Table 44. Global Decentralized Clinical Trial Platforms Company, Product Type & Application Table 45. Global Decentralized Clinical Trial Platforms Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Decentralized Clinical Trial Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Medidata Company Information Table 49. Medidata Business Overview Table 50. Medidata Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Medidata Decentralized Clinical Trial Platforms Product Portfolio Table 52. Medidata Recent Development Table 53. IQVIA Company Information Table 54. IQVIA Business Overview Table 55. IQVIA Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. IQVIA Decentralized Clinical Trial Platforms Product Portfolio Table 57. IQVIA Recent Development Table 58. Veeva Systems Company Information Table 59. Veeva Systems Business Overview Table 60. Veeva Systems Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Veeva Systems Decentralized Clinical Trial Platforms Product Portfolio Table 62. Veeva Systems Recent Development Table 63. Castor Company Information Table 64. Castor Business Overview Table 65. Castor Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Castor Decentralized Clinical Trial Platforms Product Portfolio Table 67. Castor Recent Development Table 68. Delve Health Company Information Table 69. Delve Health Business Overview Table 70. Delve Health Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Delve Health Decentralized Clinical Trial Platforms Product Portfolio Table 72. Delve Health Recent Development Table 73. Jeeva Company Information Table 74. Jeeva Business Overview Table 75. Jeeva Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Jeeva Decentralized Clinical Trial Platforms Product Portfolio Table 77. Jeeva Recent Development Table 78. Signant Health Company Information Table 79. Signant Health Business Overview Table 80. Signant Health Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Signant Health Decentralized Clinical Trial Platforms Product Portfolio Table 82. Signant Health Recent Development Table 83. Clinical Ink Company Information Table 84. Clinical Ink Business Overview Table 85. Clinical Ink Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Clinical Ink Decentralized Clinical Trial Platforms Product Portfolio Table 87. Clinical Ink Recent Development Table 88. ObvioHealth Company Information Table 89. ObvioHealth Business Overview Table 90. ObvioHealth Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ObvioHealth Decentralized Clinical Trial Platforms Product Portfolio Table 92. ObvioHealth Recent Development Table 93. THREAD Company Information Table 94. THREAD Business Overview Table 95. THREAD Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. THREAD Decentralized Clinical Trial Platforms Product Portfolio Table 97. THREAD Recent Development Table 98. Science 37 Company Information Table 99. Science 37 Business Overview Table 100. Science 37 Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Science 37 Decentralized Clinical Trial Platforms Product Portfolio Table 102. Science 37 Recent Development Table 103. Medable, Clario Company Information Table 104. Medable, Clario Business Overview Table 105. Medable, Clario Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Medable, Clario Decentralized Clinical Trial Platforms Product Portfolio Table 107. Medable, Clario Recent Development Table 108. Aparito Company Information Table 109. Aparito Business Overview Table 110. Aparito Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Aparito Decentralized Clinical Trial Platforms Product Portfolio Table 112. Aparito Recent Development Table 113. Viedoc Technologies Company Information Table 114. Viedoc Technologies Business Overview Table 115. Viedoc Technologies Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Viedoc Technologies Decentralized Clinical Trial Platforms Product Portfolio Table 117. Viedoc Technologies Recent Development Table 118. Crucial Data Solutions Company Information Table 119. Crucial Data Solutions Business Overview Table 120. Crucial Data Solutions Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Crucial Data Solutions Decentralized Clinical Trial Platforms Product Portfolio Table 122. Crucial Data Solutions Recent Development Table 123. Medrio Company Information Table 124. Medrio Business Overview Table 125. Medrio Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Medrio Decentralized Clinical Trial Platforms Product Portfolio Table 127. Medrio Recent Development Table 128. Alira Health Company Information Table 129. Alira Health Business Overview Table 130. Alira Health Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Alira Health Decentralized Clinical Trial Platforms Product Portfolio Table 132. Alira Health Recent Development Table 133. Fortrea Company Information Table 134. Fortrea Business Overview Table 135. Fortrea Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Fortrea Decentralized Clinical Trial Platforms Product Portfolio Table 137. Fortrea Recent Development Table 138. Huma Company Information Table 139. Huma Business Overview Table 140. Huma Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Huma Decentralized Clinical Trial Platforms Product Portfolio Table 142. Huma Recent Development Table 143. Cliniv Health Tech Company Information Table 144. Cliniv Health Tech Business Overview Table 145. Cliniv Health Tech Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Cliniv Health Tech Decentralized Clinical Trial Platforms Product Portfolio Table 147. Cliniv Health Tech Recent Development Table 148. Datacubed Health Company Information Table 149. Datacubed Health Business Overview Table 150. Datacubed Health Decentralized Clinical Trial Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Datacubed Health Decentralized Clinical Trial Platforms Product Portfolio Table 152. Datacubed Health Recent Development Table 153. North America Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Decentralized Clinical Trial Platforms Market Share by Country (2021-2026) Table 156. North America Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Decentralized Clinical Trial Platforms Market Share Forecast by Country (2027-2032) Table 158. Europe Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Decentralized Clinical Trial Platforms Market Share by Country (2021-2026) Table 161. Europe Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Decentralized Clinical Trial Platforms Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Decentralized Clinical Trial Platforms Market Share by Country (2021-2026) Table 166. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Decentralized Clinical Trial Platforms Market Share Forecast by Country (2027-2032) Table 168. Latin America Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Decentralized Clinical Trial Platforms Market Share by Country (2021-2026) Table 171. Latin America Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Decentralized Clinical Trial Platforms Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Country (2021-2026) Table 176. Middle East & Africa Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Decentralized Clinical Trial Platforms Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Decentralized Clinical Trial Platforms Product Image Figure 3. Global Decentralized Clinical Trial Platforms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 5. Global Decentralized Clinical Trial Platforms Market Share by Region: 2025 VS 2032 Figure 6. Global Decentralized Clinical Trial Platforms Market Share by Region (2021-2032) Figure 7. North America Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cloud Based Image Figure 13. Global Cloud Based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Web Based Image Figure 15. Global Web Based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Decentralized Clinical Trial Platforms Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Decentralized Clinical Trial Platforms Market Share by Type 2025 VS 2032 Figure 18. North America Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2032) Figure 19. Europe Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2032) Figure 21. Latin America Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2032) Figure 23. Pharmaceutical Companies Image Figure 24. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Biotechnology Firms Image Figure 26. Global Biotechnology Firms Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Contract Research Organizations (CROs) Image Figure 28. Global Contract Research Organizations (CROs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Healthcare Institutions Image Figure 30. Global Healthcare Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Decentralized Clinical Trial Platforms Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Decentralized Clinical Trial Platforms Market Share by Application 2025 VS 2032 Figure 33. North America Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2032) Figure 34. Europe Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2032) Figure 36. Latin America Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Decentralized Clinical Trial Platforms Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Decentralized Clinical Trial Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Decentralized Clinical Trial Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 43. Europe Decentralized Clinical Trial Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Decentralized Clinical Trial Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 46. Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Decentralized Clinical Trial Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 49. Latin America Decentralized Clinical Trial Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Decentralized Clinical Trial Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 52. Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • Web Based
Applications
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Contract Research Organizations (CROs)
  • Healthcare Institutions
Companies covered
  • Medidata
  • IQVIA
  • Veeva Systems
  • Castor
  • Delve Health
  • Jeeva
  • Signant Health
  • Clinical Ink
  • ObvioHealth
  • THREAD
  • Science 37
  • Medable, Clario
  • Aparito
  • Viedoc Technologies
  • Crucial Data Solutions
  • Medrio
  • Alira Health
  • Fortrea
  • Huma
  • Cliniv Health Tech
  • Datacubed Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Decentralized Clinical Trial Platforms Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Decentralized Clinical Trial Platforms Market Size by Region (2021-2032)
  5. 1.4.1 Global Decentralized Clinical Trial Platforms Market Size by Region (2021-2026)
  6. 1.4.2 Global Decentralized Clinical Trial Platforms Market Size by Region (2027-2032)
  7. 1.5 Key Regions Decentralized Clinical Trial Platforms Market Size (2021-2032)
  8. 1.5.1 North America Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Decentralized Clinical Trial Platforms Market Size Growth Rate (2021-2032)
2 Decentralized Clinical Trial Platforms Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cloud Based
  3. 2.1.2 Web Based
  4. 2.2 Global Decentralized Clinical Trial Platforms Market Size by Type
  5. 2.2.1 Global Decentralized Clinical Trial Platforms Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Decentralized Clinical Trial Platforms Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Decentralized Clinical Trial Platforms Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Decentralized Clinical Trial Platforms Market Size by Regions
  9. 2.3.1 North America Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Decentralized Clinical Trial Platforms Market Size Breakdown by Type (2021-2026)
3 Decentralized Clinical Trial Platforms Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Companies
  3. 3.1.2 Biotechnology Firms
  4. 3.1.3 Contract Research Organizations (CROs)
  5. 3.1.4 Healthcare Institutions
  6. 3.2 Global Decentralized Clinical Trial Platforms Market Size by Application
  7. 3.2.1 Global Decentralized Clinical Trial Platforms Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Decentralized Clinical Trial Platforms Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Decentralized Clinical Trial Platforms Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Decentralized Clinical Trial Platforms Market Size by Regions
  11. 3.3.1 North America Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Decentralized Clinical Trial Platforms Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Decentralized Clinical Trial Platforms Industry Trends
  2. 4.2 Decentralized Clinical Trial Platforms Industry Drivers
  3. 4.3 Decentralized Clinical Trial Platforms Industry Opportunities and Challenges
  4. 4.4 Decentralized Clinical Trial Platforms Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Decentralized Clinical Trial Platforms Revenue (2021-2026)
  2. 5.2 Global Decentralized Clinical Trial Platforms Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Decentralized Clinical Trial Platforms Key Company Headquarters & Area Served
  4. 5.4 Global Decentralized Clinical Trial Platforms Company, Product Type & Application
  5. 5.5 Global Decentralized Clinical Trial Platforms Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Decentralized Clinical Trial Platforms Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Decentralized Clinical Trial Platforms Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Decentralized Clinical Trial Platforms Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Medidata
  2. 6.1.1 Medidata Company Information
  3. 6.1.2 Medidata Business Overview
  4. 6.1.3 Medidata Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Medidata Decentralized Clinical Trial Platforms Product Portfolio
  6. 6.1.5 Medidata Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 IQVIA Decentralized Clinical Trial Platforms Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 Veeva Systems
  14. 6.3.1 Veeva Systems Company Information
  15. 6.3.2 Veeva Systems Business Overview
  16. 6.3.3 Veeva Systems Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Veeva Systems Decentralized Clinical Trial Platforms Product Portfolio
  18. 6.3.5 Veeva Systems Recent Developments
  19. 6.4 Castor
  20. 6.4.1 Castor Company Information
  21. 6.4.2 Castor Business Overview
  22. 6.4.3 Castor Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Castor Decentralized Clinical Trial Platforms Product Portfolio
  24. 6.4.5 Castor Recent Developments
  25. 6.5 Delve Health
  26. 6.5.1 Delve Health Company Information
  27. 6.5.2 Delve Health Business Overview
  28. 6.5.3 Delve Health Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Delve Health Decentralized Clinical Trial Platforms Product Portfolio
  30. 6.5.5 Delve Health Recent Developments
  31. 6.6 Jeeva
  32. 6.6.1 Jeeva Company Information
  33. 6.6.2 Jeeva Business Overview
  34. 6.6.3 Jeeva Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Jeeva Decentralized Clinical Trial Platforms Product Portfolio
  36. 6.6.5 Jeeva Recent Developments
  37. 6.7 Signant Health
  38. 6.7.1 Signant Health Company Information
  39. 6.7.2 Signant Health Business Overview
  40. 6.7.3 Signant Health Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Signant Health Decentralized Clinical Trial Platforms Product Portfolio
  42. 6.7.5 Signant Health Recent Developments
  43. 6.8 Clinical Ink
  44. 6.8.1 Clinical Ink Company Information
  45. 6.8.2 Clinical Ink Business Overview
  46. 6.8.3 Clinical Ink Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Clinical Ink Decentralized Clinical Trial Platforms Product Portfolio
  48. 6.8.5 Clinical Ink Recent Developments
  49. 6.9 ObvioHealth
  50. 6.9.1 ObvioHealth Company Information
  51. 6.9.2 ObvioHealth Business Overview
  52. 6.9.3 ObvioHealth Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ObvioHealth Decentralized Clinical Trial Platforms Product Portfolio
  54. 6.9.5 ObvioHealth Recent Developments
  55. 6.10 THREAD
  56. 6.10.1 THREAD Company Information
  57. 6.10.2 THREAD Business Overview
  58. 6.10.3 THREAD Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 THREAD Decentralized Clinical Trial Platforms Product Portfolio
  60. 6.10.5 THREAD Recent Developments
  61. 6.11 Science 37
  62. 6.11.1 Science 37 Company Information
  63. 6.11.2 Science 37 Business Overview
  64. 6.11.3 Science 37 Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Science 37 Decentralized Clinical Trial Platforms Product Portfolio
  66. 6.11.5 Science 37 Recent Developments
  67. 6.12 Medable, Clario
  68. 6.12.1 Medable, Clario Company Information
  69. 6.12.2 Medable, Clario Business Overview
  70. 6.12.3 Medable, Clario Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Medable, Clario Decentralized Clinical Trial Platforms Product Portfolio
  72. 6.12.5 Medable, Clario Recent Developments
  73. 6.13 Aparito
  74. 6.13.1 Aparito Company Information
  75. 6.13.2 Aparito Business Overview
  76. 6.13.3 Aparito Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Aparito Decentralized Clinical Trial Platforms Product Portfolio
  78. 6.13.5 Aparito Recent Developments
  79. 6.14 Viedoc Technologies
  80. 6.14.1 Viedoc Technologies Company Information
  81. 6.14.2 Viedoc Technologies Business Overview
  82. 6.14.3 Viedoc Technologies Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Viedoc Technologies Decentralized Clinical Trial Platforms Product Portfolio
  84. 6.14.5 Viedoc Technologies Recent Developments
  85. 6.15 Crucial Data Solutions
  86. 6.15.1 Crucial Data Solutions Company Information
  87. 6.15.2 Crucial Data Solutions Business Overview
  88. 6.15.3 Crucial Data Solutions Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Crucial Data Solutions Decentralized Clinical Trial Platforms Product Portfolio
  90. 6.15.5 Crucial Data Solutions Recent Developments
  91. 6.16 Medrio
  92. 6.16.1 Medrio Company Information
  93. 6.16.2 Medrio Business Overview
  94. 6.16.3 Medrio Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Medrio Decentralized Clinical Trial Platforms Product Portfolio
  96. 6.16.5 Medrio Recent Developments
  97. 6.17 Alira Health
  98. 6.17.1 Alira Health Company Information
  99. 6.17.2 Alira Health Business Overview
  100. 6.17.3 Alira Health Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Alira Health Decentralized Clinical Trial Platforms Product Portfolio
  102. 6.17.5 Alira Health Recent Developments
  103. 6.18 Fortrea
  104. 6.18.1 Fortrea Company Information
  105. 6.18.2 Fortrea Business Overview
  106. 6.18.3 Fortrea Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Fortrea Decentralized Clinical Trial Platforms Product Portfolio
  108. 6.18.5 Fortrea Recent Developments
  109. 6.19 Huma
  110. 6.19.1 Huma Company Information
  111. 6.19.2 Huma Business Overview
  112. 6.19.3 Huma Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Huma Decentralized Clinical Trial Platforms Product Portfolio
  114. 6.19.5 Huma Recent Developments
  115. 6.20 Cliniv Health Tech
  116. 6.20.1 Cliniv Health Tech Company Information
  117. 6.20.2 Cliniv Health Tech Business Overview
  118. 6.20.3 Cliniv Health Tech Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Cliniv Health Tech Decentralized Clinical Trial Platforms Product Portfolio
  120. 6.20.5 Cliniv Health Tech Recent Developments
  121. 6.21 Datacubed Health
  122. 6.21.1 Datacubed Health Company Information
  123. 6.21.2 Datacubed Health Business Overview
  124. 6.21.3 Datacubed Health Decentralized Clinical Trial Platforms Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Datacubed Health Decentralized Clinical Trial Platforms Product Portfolio
  126. 6.21.5 Datacubed Health Recent Developments
7 North America
  1. 7.1 North America Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  3. 7.3 North America Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  3. 8.3 Europe Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  3. 10.3 South America Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Decentralized Clinical Trial Platforms Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst